|
Market Closed -
Nasdaq
01:30:00 29/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.110 USD | -1.77% |
|
-39.01% | -79.33% |
| 23/09 | Compass Therapeutics Shares Drop After Downgrade From Wedbush | MT |
| 23/09 | Wedbush Downgrades Compass Therapeutics to Neutral From Outperform, Cuts Price Target to $1 From $5 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 20Cr | - | - | - | - | - |
| 7.23TCr | |||||
| 6.02TCr | |||||
| 2.77TCr | |||||
| 2.57TCr | - | ||||
| 2.47TCr | - |
Select your edition
All financial news and data tailored to specific country editions
